Anti-Fibrillin-1 Autoantibodies in Systemic Sclerosis Are GM and KM Allotype-Restricted

Publisher： Karger

E-ISSN： 1421-9948|18|3|123-129

ISSN： 0254-9670

Source： Experimental and Clinical Immunogenetics, Vol.18, Iss.3, 2001-09, pp. : 123-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunoglobulin GM and KM Allotypes in Systemic Lupus erythematosus

By  

Experimental and Clinical Immunogenetics, Vol. 18, Iss. 3, 2001-09 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Clinical and Immunologic Predictors of Scleroderma Renal Crisis in Japanese Systemic Sclerosis Patients With Anti–RNA Polymerase III Autoantibodies

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 4, 2015-04 ,pp. : 1045-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epitope Specificity Determines Pathogenicity and Detectability of Anti–Platelet‐Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 7, 2015-07 ,pp. : 1891-1903

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoantibodies to Vimentin‐type Intermediate Filament in Patients with Progressive Systemic Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 15, Iss. 2, 1988-04 ,pp. : 128-132

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is the Measurement of Anti–PM‐1α Antibodies at Least as Important as That of Other Systemic Sclerosis–Specific Antibodies? Comment on the Article by D'Aoust et al

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 11, 2014-11 ,pp. : 3248-3248

John Wiley & Sons Inc

Access to resources Recommend Favorite